Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2024-08-17 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2024-08-17 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official communication dated 17th August 2024, addressed to stock exchanges (BSE and NSE) regarding the outcome of the Annual General Meeting (AGM) held on the same day. It references Regulation 30 of SEBI Listing Regulations, which governs disclosure of material events. The content includes resolutions passed at the AGM such as adoption of audited financial statements, dividend declaration, and director appointment. It explicitly states that the proceedings of the AGM, Scrutinizers Report, and Voting Results will be uploaded separately, indicating this document is a summary or announcement of the AGM outcome rather than the full AGM materials or reports themselves. The document length is short (2166 characters), and it serves as an announcement of the AGM results rather than the AGM presentation or full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-08-17 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the loss of a share certificate. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss reporting. The content is a notification about a specific administrative issue related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. This type of document fits best under Regulatory Filings (RNS), as it is a compliance-related announcement that does not fit other specific categories.
2024-08-09 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as a presentation on unaudited financial results for the quarter ended 30th June 2024 (Q1FY25). It contains detailed financial data including income statements, segmental revenue, historical financials, and business highlights. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content is consistent with an investor presentation focusing on financials, strategy, and market position rather than a formal earnings release or annual report. Therefore, the document fits the category of an Investor Presentation (IP).
2024-08-07 English
Financial Result Updates
Regulatory Filings
2024-08-07 English
Board Meeting — NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Compan…
Regulatory Filings
2024-07-30 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.